Compare SNY to:
Real-Time: 37.82 -0.61 (-1.59%) 12:49pm ET
| Last Trade: | 37.76 |
|---|---|
| Trade Time: | 12:34pm ET |
| Change: | |
| Prev Close: | 38.43 |
| Open: | 37.89 |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 43.50 |
| Day's Range: | 37.72 - 38.36 |
|---|---|
| 52wk Range: | 24.59 - 40.17 |
| Volume: | 398,917 |
| Avg Vol (3m): | 1,410,270 |
| Market Cap: | 98.60B |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | 1.42 (3.70%) |
| Mon 12:20pm | Vaccines: Hopes of prevention receive shot in the armat FT.com |
| Mon 11:44am | [$$] Weinberg May Succeed Sanofi Chairmanat The Wall Street Journal Online |
| Mon 9:26am | Sanofi-aventis Canada announces licensing agreement with Intelliject for novel epinephrine auto injectorCNW Group |
| Mon 8:31am | InPlay: Sanofi-Aventis unit signs exclusive licensing agreement with IntellijectBriefing.com |
| Mon 8:30am | Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North AmericaPR Newswire |
| Mon 5:17am | [$$] Sanofi-Aventis Cardiovascular Drug Multaq Gets EU Approvalat The Wall Street Journal Online |
| Mon 2:09am | Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial FibrillationPR Newswire |
| Sun 12:45pm | Turning the world of drugs upside downat FT.com |
| Fri, Nov 27 | European shares rise as banks regain poiseat FT.com |
| Fri, Nov 27 | Sanofi-Aventis to participate in Russian projectat MarketWatch |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.